Apollo Hospitals announces special dividend amid record quarter growth and leadership renewal

Apollo Hospitals reports a 36% rise in quarterly net profit to ₹529 crore, announces a final dividend of ₹10 per share, and reappoints founder-chairman Prathap C Reddy, signalling strong growth and strategic stability.

Apollo Hospitals Enterprise is handing shareholders another cash reward after reporting a strong rise in quarterly profit, underscoring the Chennai-based group’s continued expansion across hospitals and pharmacy operations. According to Livemint, net profit climbed 36% year on year to ₹529 crore in the fourth quarter of FY26, alongside the announcement of a final dividend of ₹10 a share, equal to 200% of face value. The record date is August 14, 2026, and the payout, if approved, is due on or before September 10.

The dividend still needs shareholder approval at the company’s annual general meeting, scheduled for August 25. Zee Business reported that Apollo has also said August 14 will serve as the ex-date for investors seeking to qualify for the payout. The company had already paid an interim dividend of ₹10 a share earlier in the year, according to Livemint’s dividend data.

Apollo’s board has also cleared the reappointment of founder-chairman Prathap C Reddy as executive chairman for another two years, effective June 25, 2026, subject to shareholder approval. The company said he is not barred from holding office by any SEBI order or other authority. Apollo’s own material says Reddy founded the group in 1983 and helped build one of India’s best-known private healthcare networks.

The latest dividend comes as investors look ahead to what Zee Business described as expected solid first-quarter FY27 numbers. Its estimates point to revenue rising 18% to ₹6,898 crore, with EBITDA up 23% to ₹1,051 crore and profit after tax climbing 29% to ₹557 crore. The forecast assumes support from new bed additions, stronger inpatient volumes and growth in HealthCo and offline pharmacy distribution.

Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.